Company
Recode TX
Powering the future of genetic medicines with precision delivery
Also known as ReCode, ReCode Therapeutics, ReCode Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- ReCode Therapeutics, Inc.
- recodetx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
ReCode is developing therapeutics for genetically defined diseases with no existing treatment options including cystic fibrosis and primary ciliary dyskinesia.
Funding snapshot
- Total raised
- $319MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed2025-09-29
Funding rounds
- Round, 2025
- $29.4M2025-09-23, SEC form D sold, 26 investors
- Round, 2021
- $260M2021-10-13, SEC form D sold, 28 investors
- Round, 2020
- $27.5M2020-03-06, SEC form D sold, 9 investors
- Round, 2016
- $2M2016-12-16, SEC form D sold, 1 investor
Loading relationship preview